Release date: 2016-11-16
  "Made in China 2025" has clearly proposed to improve the innovation capability and industrialization level of medical devices, focus on the development of high-performance medical equipment, and gradually get rid of the situation that high-end medical devices rely on imports.
At present, the overall scientific and technological level of China's domestically produced devices has a gap of 10 years or so in developed countries or regions, mainly reflected in the small scale of enterprises and weak competitiveness; insufficient investment in research and development; insufficient support for domestic medical institutions to purchase and use domestically produced devices; The overall base is still slightly weak.
The convergence of technology and capital concentration is the key to the transformation of the medical device industry. It requires the international first-class scientific research team, industry leaders and high-level projects to connect with venture capital to promote the production of high-end medical devices. Strengthen cooperation with high-level research institutes, apply national scientific research projects to the industry, form complementary advantages, and effectively use resources.
China's high-end medical device development needs to break the monopoly of foreign giants; it should attach great importance to the "Internet" thinking, through the integration of resources, to cultivate medical device medical services, including medical devices + Internet, data processing centers + independent software, clinical samples + personality Sharing medical products such as products.
Large-scale high-precision diagnostic instruments such as CT, MRI, nuclear medicine, and angiography DSA have long been monopolized by foreign giants such as “GPS†(GE General Electric, Philips Netherlands, Siemens, Siemens, Germany). .
Multinational medical device companies use market monopoly positions to continuously raise prices of products and after-sales services. In the aftermarket and consumables sector, the annual warranty price for imported medical devices has soared from 6% of contract fees more than a decade ago to nearly 15% today.
According to the "Made in China 2025" strategy, the focus is on medical robots, wearable medical equipment, mobile and remote medical equipment, and radiation therapy. From a macro perspective, we should formulate the industrial development plan such as the 13th Five-Year Plan for China's Medical Device Innovation and Development, clarify development goals and policy measures, seize the frontier areas to explore and research, and coordinate the efforts of all parties to accelerate the industrial innovation of domestic medical devices. And technological progress.
Source: Report Hall
Seeds,Palay Seeds,Hybrid Palay Seeds,Palay Seeds Variety
XIKE AGRICULTURAL GROUP CO . .LTD. , https://www.laoseed.com